A systematic study of critical miRNAs on cells proliferation and apoptosis by the shortest path

Peng Xu1,2, Qian Wu3, Deyang Lu1

  • 1Institute of computational science and technology, Guangzhou University, Guangzhou, 510006, Guangdong, China.

BMC Bioinformatics
|September 7, 2020
PubMed
Abstract

Insights

This study reveals key microRNAs (miRNAs) impacting cell proliferation and apoptosis, crucial for cancer development. Findings highlight specific miRNAs linked to breast and liver cancers, offering potential for new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs involved in tumorigenesis by regulating gene expression.
  • Imbalances in cell proliferation and apoptosis are critical in cancer initiation and progression.
  • The systematic impact of miRNAs on cell fate regulation in cancer remains understudied.

Purpose of the Study:

  • To systematically investigate the role of miRNAs in regulating cell proliferation and apoptosis during tumorigenesis.
  • To identify key miRNAs influencing cell fate and their potential as cancer biomarkers or therapeutic targets.

Main Methods:

  • Construction of a cell fate miRNA-gene regulatory network.
  • Development of a shortest path-based method to calculate the global impact of miRNAs on cell fate genes.
  • Analysis of breast and liver cancer datasets, including miRNA-gene interactions, functional enrichment, drug sensitivity, and survival data.

Main Results:

  • Most cell fate genes are perturbed by differentially expressed miRNAs in breast and liver cancers.
  • Top-identified miRNAs are associated with these cancers and regulate multiple cell fate-related functions.
  • Several top miRNAs influence sensitivity or resistance to anti-cancer drugs and correlate significantly with patient survival.

Conclusions:

  • This study systematically elucidates the critical role of miRNAs in controlling proliferation and apoptosis during cancer development.
  • Identified key miRNAs provide insights into tumorigenesis and potential avenues for miRNA-based cancer therapies.
  • The findings support the development of clinical strategies utilizing miRNAs for cancer treatment and prognosis.